Vyvanse™: Consistent symptom control for ADHD

Along with Vyvanse^®, SHINE is here to provide you with consistent support. SHINE provides free practical tools, tips, and offers to help you create a comprehensive treatment program for your child. With consistent ADHD symptom control and the support of SHINE, there is no stopping your child, even through the challenging homework hours from 4 pm to 6 pm.

Some of the features of SHINE:

	Tips to improve focus, organization and behavior in your child
	Suggestions for working with your child's teachers
	Vyvanse Success Tracker
	Ideas for building and coaching your child's support team
	Additional ADHD information from Shire

Already registered for SHINE? Sign In Here

*Required Fields
*First Name:
*Last Name:
*Address 1:
Address 2:
*City:
*State:
*ZIP Code:
Phone:
*Email (This will be your User Name):
*Email (confirm your User Name):
*Password:
*Password (confirm your password):
*Date of birth of the person with ADHD:
*Gender of the person with ADHD:

All personal information you provide will be kept completely private and will not be used or distributed to anyone for any purpose other than what is explained here.

*1. Has your child been diagnosed with ADHD by a healthcare professional?

Yes

Adderall XR^® is a registered trademark of Shire LLC.

Daytrana^™ is a trademark of Shire Pharmaceuticals Ireland Limited.

Vyvanse^® is a registered trademark of Shire LLC.

All other product names are the trademarks of their respective companies.

Important Safety Information

Vyvanse is indicated for the treatment of ADHD. Efficacy based on two controlled trials in children aged 6 to 12 and one controlled trial in adults.

Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems, such as chest pain or fainting.

Vyvanse should not be taken if you or your child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; glaucoma; a history of problems with alcohol or drugs; agitated states; taken a monoamine oxidase inhibitor (MAOI) within the last 14 days.

Tell the doctor before taking Vyvanse if you or your child is being treated for or has symptoms of depression (sadness, worthlessness, or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse.

Abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with amphetamine use.

Vyvanse was generally well tolerated in clinical studies. The most common side effects reported in studies of Vyvanse were: children – decreased appetite, difficulty falling asleep, stomachache, and irritability; adult – decreased appetite, difficulty falling asleep, and dry mouth.

Aggression, new abnormal thoughts/behaviors, mania, growth suppression, worsening of motion or verbal tics, and Tourette’s syndrome have been associated with use of drugs of this type. Tell the doctor if you or your child has blurred vision while taking Vyvanse.

Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

LDX2979 08/08